Next Article in Journal
Skin Cleansing without or with Compromise: Soaps and Syndets
Next Article in Special Issue
Dystrophin Protein Quantification as a Duchenne Muscular Dystrophy Diagnostic Biomarker in Dried Blood Spots Using Multiple Reaction Monitoring Tandem Mass Spectrometry: A Preliminary Study
Previous Article in Journal
Manufacturing and Assessing the New Orally Disintegrating Tablets, Containing Nimodipine-hydroxypropyl-β-cyclodextrin and Nimodipine-methyl-β-cyclodextrin Inclusion Complexes
Previous Article in Special Issue
LC-MS/MS Analysis Elucidates a Daily Rhythm in Orexin A Concentration in the Rat Vitreous Body
 
 
Article
Peer-Review Record

Quantitative Analysis of Daporinad (FK866) and Its In Vitro and In Vivo Metabolite Identification Using Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometry

Molecules 2022, 27(6), 2011; https://doi.org/10.3390/molecules27062011
by Minjae Park, Byeong Ill Lee, Jangmi Choi, Yuri Park, Seo-Jin Park, Jeong-Hyeon Lim, Jiyu Lee and Young G. Shin *
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Molecules 2022, 27(6), 2011; https://doi.org/10.3390/molecules27062011
Submission received: 8 March 2022 / Revised: 16 March 2022 / Accepted: 17 March 2022 / Published: 21 March 2022
(This article belongs to the Special Issue LC-MS in Bioanalysis)

Round 1

Reviewer 1 Report

The present manuscript entitled "Quantitative Analysis of Daporinad (FK866) and Its In vitro and In vivo Metabolite Identification Using Liquid Chromatography-Quadrupole-Time-Of-Flight Mass Spectrometry" by Minjae Park, Byeong ill Lee, Jangmi Choi, Yuri Park, Seo-jin Park, Jeong-hyun Lim, Jiyu Lee, and Young G. Shin (molecules-1649950) describes the development of a simple and sensitive liquid chromatography-quadrupole time of flight mass spectrometry method to investigate the pharmacokinetic properties of daporinad in mouse plasma. Additionally, in vitro and in vivo metabolite identification was also checked.

The present article is written correctly and has a good structure; moreover, it has all the necessary parts. The article is interesting from an analytical point of view; therefore, it should interest the reader. The paper meets Molecules' requirements, and I recommend the article for publication in Molecules following the common editing stage. My current decision is a major revision. More specific comments and observations are presented below.

  1. The most important consideration concerns the validation of the analytical procedure. If a new method is described, it should be validated, which is currently missing in the article. Please add a section on the validation of the analytical procedure. Validation parameters can be mentioned in the abstract.
  2. Introduction. One paragraph about analytical techniques for testing this compound may be added.
  3. Figures. Giving values only at the beginning and end of the axis is not informative. Please add a few values between the beginning and the end.
  4. Figure 2a. Please, replace commas with dots.
  5. Has the interference been studied? What can be done in the event of strong interference effects? How would you deal with them? What types of interference effects could occur?
  6. Figure 3. The drawing border should be removed. The axes should be more clearly marked.
  7. Table 4. Explanations of the abbreviations used should be placed under the table. Please check that all used abbreviations are explained beforehand.
  8. Figure 5. The inscriptions are not clearly visible.
  9. Figure 6. You can enlarge the axis description along with the values. The chemical formulas are strangely stretched. The red frame is too thick.
  10. Figure 7. The chemical formulas are strangely stretched. The inscriptions are not clearly visible.
  11. Section 3.1. A very monotonous description. Tu much “were purchased”.
  12. References. Please adapt it to the requirements of the journal. Journal abbreviations are not used.

I hope that the comments presented will help improve the article.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

1. Introduction: the authors should discuss in detail the following publication dealing with the same topic

Qu, S.-D., Liu, G.-X.
Daporinad in vitro metabolite profiling via rat, dog, monkey and human liver microsomes by liquid chromatography/quadrupole-orbitrap mass spectrometry (2021) Rapid Communications in Mass Spectrometry, 35 (18), art. no. e9150

2. Linearity: please check the significant figures; is 1.02 a valid concentration level?

3. Tables 1, 2 and 3: please correct the significant figures.

4. Validation parameters are missing; please refer to the guidelines you followed for method validation.

5. Lines 180-285: can be presented as supplementary material.

6. Section 3.1: please provide purities where approapriate.

7. Line 340: Is there a specific reason for reconstitution in 110 μL and not in 100 μL?

8. Please provide the ethical permission number / code for animal experiments 

 

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Round 2

Reviewer 1 Report

Dear Authors,

Thank you for your meticulous consideration of my comments. The paper has improved substantially and, to my opinion, is suitable for publication.

Reviewer 2 Report

The revised version is satisfactory and suitable for publication. 

Back to TopTop